HeartBeam, Inc. financial data

Symbol
BEAT, BEATW on Nasdaq
Location
Santa Clara, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 253% %
Debt-to-equity 54% % 309%
Return On Equity -599% % -241%
Return On Assets -388% % -151%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 34,443,563 shares 29%
Common Stock, Shares, Outstanding 34,340,727 shares 29%
Entity Public Float $55,733,467 USD 161%
Common Stock, Value, Issued $4,000 USD 33%
Weighted Average Number of Shares Outstanding, Basic 34,396,431 shares 29%
Weighted Average Number of Shares Outstanding, Diluted 34,396,431 shares 29%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $12,982,000 USD 28%
General and Administrative Expense $7,793,000 USD -12%
Operating Income (Loss) $20,775,000 USD -9%
Nonoperating Income (Expense) $155,000 USD -75%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $20,620,000 USD -12%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $20,620,000 USD -12%
Earnings Per Share, Basic 0 USD/shares -38%
Earnings Per Share, Diluted 0 USD/shares -38%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $1,856,000 USD -68%
Cash, Cash Equivalents, and Short-term Investments $1,900,000 USD
Assets, Current $2,126,000 USD -65%
Property, Plant and Equipment, Net $694,000 USD 52%
Other Assets, Noncurrent $56,000 USD 0%
Assets $2,876,000 USD -57%
Accounts Payable, Current $1,021,000 USD
Accrued Liabilities, Current $1,449,000 USD
Liabilities, Current $2,470,000 USD 33%
Liabilities $2,470,000 USD 33%
Retained Earnings (Accumulated Deficit) $71,986,000 USD -40%
Stockholders' Equity Attributable to Parent $406,000 USD -92%
Liabilities and Equity $2,876,000 USD -57%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $4,477,000 USD -29%
Net Cash Provided by (Used in) Financing Activities $10,250,000 USD
Net Cash Provided by (Used in) Investing Activities $3,760,000 USD -4173%
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 34,340,727 shares 29%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $2,013,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1,912,000 USD -67%
Deferred Tax Assets, Valuation Allowance $12,927,600 USD 42%
Deferred Tax Assets, Gross $12,929,300 USD 42%
Depreciation $7,000 USD
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Property, Plant and Equipment, Gross $0 USD
Deferred Tax Assets, Operating Loss Carryforwards $7,479,400 USD 29%
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $357,900 USD 25%
Additional Paid in Capital $72,388,000 USD 29%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $4,337,736 USD -0.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%